Malignant Neoplasm of the Stomach B002

Current RMA Instruments
Reasonable Hypothesis SOP
74 of 2023
Balance of Probabilities SOP
75 of 2023
Changes from previous Instruments

ICD Coding

ICD-10-AM Code: C16

Brief description

Gastric cancer is one of the most common cancers worldwide, though is less common in Western countries.  There are a number of sub-types of the disease with the most common being adenocarcinoma.  This SOP covers primary epithelial cancers of the cardia, body, antrum and pyloris of the stomach. 

Confirming the diagnosis

Histology (from biopsy, an excised specimen, or autopsy) is required to confirm the diagnosis and apply the SOP.  Information on whether the primary site is the cardia of the stomach (near the oesophagus), or the rest of the stomach, will be needed to apply some of the SOP factors.

The relevant medical specialist is an oncologist, general surgeon, or gastroenterologist.

Diagnoses covered by SOP
  • adeno-, adenosquamous-, chorio-, diffuse-, intestinal-, squamous-, poorly differentiated- and undifferentiated- carcinoma of the stomach; (including mucinous, papillary, signet ring and tubular adenocarcinoma of the stomach)
  • carcinoma of the (gastric) cardia
  • carcinoma of the stomach
  • gastric carcinoma
  • linitis plastica
Conditions excluded from SOP
  • carcinoid of the stomach#
  • gastroblastoma#
  • soft tissue sarcoma of the stomach*
  • non-Hodgkin lymphoma of the stomach*
  • Hodgkin lymphoma of the stomach*
  • MALT lymphoma of the stomach - non-Hodgkin lymphoma SOP
  • neuroendocrine tumour of the stomach#
  • Secondary/metastatic cancer/carcinoma involving the stomach (code to primary cancer site)

* another SOP applies

# non-SOP condition

Clinical onset

The condition typically presents at a late stage.  Unintentional weight loss, early satiety (feeling full after consuming only a small amount of food), persistent indigestion and abdominal pain are the most common symptoms.  Other presentations can include dysphagia (difficulty swallowing), nausea, vomiting, and black tarry stools (indicating gastrointestinal bleeding). 

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management.  Most people present with advanced, incurable disease and have a poor prognosis even with treatment.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/m/malignant-neoplasm-stomach-b002-c16

Last amended

Rulebase for malignant neoplasm of the stomach

<h5>Current RMA Instruments</h5><table border="1" cellpadding="1" cellspacing="1"><tbody><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2023/3956562953/074.pdf&quot; target="_blank">Reasonable Hypothesis SOP</a></address></td><td>74 of 2023</td></tr><tr><td><address><a href="http://www.rma.gov.au/assets/SOP/2023/f7b99f3c37/075.pdf&quot; target="_blank">Balance of Probabilities SOP </a></address></td><td>75 of 2023</td></tr></tbody></table><h5>Changes from previous Instruments</h5><p><drupal-media data-entity-type="media" data-entity-uuid="94fe6d48-c557-47fc-942a-c381b6bdde6c" data-view-mode="wysiwyg"></drupal-media></p><h5>ICD Coding</h5><p>ICD-10-AM Code: C16</p><h5>Brief description</h5><p>Gastric cancer is one of the most common cancers worldwide, though is less common in Western countries.  There are a number of sub-types of the disease with the most common being adenocarcinoma.  This SOP covers primary epithelial cancers of the cardia, body, antrum and pyloris of the stomach. </p><h5><strong>Confirming the diagnosis</strong></h5><p>Histology (from biopsy, an excised specimen, or autopsy) is required to confirm the diagnosis and apply the SOP.  Information on whether the primary site is the cardia of the stomach (near the oesophagus), or the rest of the stomach, will be needed to apply some of the SOP factors.</p><p>The relevant medical specialist is an oncologist, general surgeon, or gastroenterologist.</p><h5><strong>Diagnoses covered by SOP </strong></h5><ul><li>adeno-, adenosquamous-, chorio-, diffuse-, intestinal-, squamous-, poorly differentiated- and undifferentiated- carcinoma of the stomach; (including mucinous, papillary, signet ring and tubular adenocarcinoma of the stomach)</li><li>carcinoma of the (gastric) cardia</li><li>carcinoma of the stomach</li><li>gastric carcinoma</li><li>linitis plastica</li></ul><h5><strong>Conditions excluded from SOP</strong></h5><ul><li>carcinoid of the stomach#</li><li>gastroblastoma#</li><li>soft tissue sarcoma of the stomach*</li><li>non-Hodgkin lymphoma of the stomach*</li><li>Hodgkin lymphoma of the stomach*</li><li>MALT lymphoma of the stomach - non-Hodgkin lymphoma SOP</li><li>neuroendocrine tumour of the stomach#</li><li>Secondary/metastatic cancer/carcinoma involving the stomach (code to primary cancer site)</li></ul><p>* another SOP applies</p><p># non-SOP condition</p><h5>Clinical onset</h5><p>The condition typically presents at a late stage.  Unintentional weight loss, early satiety (feeling full after consuming only a small amount of food), persistent indigestion and abdominal pain are the most common symptoms.  Other presentations can include dysphagia (difficulty swallowing), nausea, vomiting, and black tarry stools (indicating gastrointestinal bleeding). </p><h5>Clinical worsening</h5><p>The only SOP worsening factor is for inability to obtain appropriate clinical management.  Most people present with advanced, incurable disease and have a poor prognosis even with treatment.</p><p> </p>

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/rulebase-malignant-neoplasm-stomach

A course of therapeutic radiation

Current RMA Instruments
Reasonable Hypothesis SOP
74 of 2023
Balance of Probabilities SOP
75 of 2023
Changes from previous Instruments

ICD Coding

ICD-10-AM Code: C16

Brief description

Gastric cancer is one of the most common cancers worldwide, though is less common in Western countries.  There are a number of sub-types of the disease with the most common being adenocarcinoma.  This SOP covers primary epithelial cancers of the cardia, body, antrum and pyloris of the stomach. 

Confirming the diagnosis

Histology (from biopsy, an excised specimen, or autopsy) is required to confirm the diagnosis and apply the SOP.  Information on whether the primary site is the cardia of the stomach (near the oesophagus), or the rest of the stomach, will be needed to apply some of the SOP factors.

The relevant medical specialist is an oncologist, general surgeon, or gastroenterologist.

Diagnoses covered by SOP
  • adeno-, adenosquamous-, chorio-, diffuse-, intestinal-, squamous-, poorly differentiated- and undifferentiated- carcinoma of the stomach; (including mucinous, papillary, signet ring and tubular adenocarcinoma of the stomach)
  • carcinoma of the (gastric) cardia
  • carcinoma of the stomach
  • gastric carcinoma
  • linitis plastica
Conditions excluded from SOP
  • carcinoid of the stomach#
  • gastroblastoma#
  • soft tissue sarcoma of the stomach*
  • non-Hodgkin lymphoma of the stomach*
  • Hodgkin lymphoma of the stomach*
  • MALT lymphoma of the stomach - non-Hodgkin lymphoma SOP
  • neuroendocrine tumour of the stomach#
  • Secondary/metastatic cancer/carcinoma involving the stomach (code to primary cancer site)

* another SOP applies

# non-SOP condition

Clinical onset

The condition typically presents at a late stage.  Unintentional weight loss, early satiety (feeling full after consuming only a small amount of food), persistent indigestion and abdominal pain are the most common symptoms.  Other presentations can include dysphagia (difficulty swallowing), nausea, vomiting, and black tarry stools (indicating gastrointestinal bleeding). 

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management.  Most people present with advanced, incurable disease and have a poor prognosis even with treatment.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-stomach-b002-c16/rulebase-malignant-neoplasm-stomach/course-therapeutic-radiation

Atomic radiation

Current RMA Instruments
Reasonable Hypothesis SOP
74 of 2023
Balance of Probabilities SOP
75 of 2023
Changes from previous Instruments

ICD Coding

ICD-10-AM Code: C16

Brief description

Gastric cancer is one of the most common cancers worldwide, though is less common in Western countries.  There are a number of sub-types of the disease with the most common being adenocarcinoma.  This SOP covers primary epithelial cancers of the cardia, body, antrum and pyloris of the stomach. 

Confirming the diagnosis

Histology (from biopsy, an excised specimen, or autopsy) is required to confirm the diagnosis and apply the SOP.  Information on whether the primary site is the cardia of the stomach (near the oesophagus), or the rest of the stomach, will be needed to apply some of the SOP factors.

The relevant medical specialist is an oncologist, general surgeon, or gastroenterologist.

Diagnoses covered by SOP
  • adeno-, adenosquamous-, chorio-, diffuse-, intestinal-, squamous-, poorly differentiated- and undifferentiated- carcinoma of the stomach; (including mucinous, papillary, signet ring and tubular adenocarcinoma of the stomach)
  • carcinoma of the (gastric) cardia
  • carcinoma of the stomach
  • gastric carcinoma
  • linitis plastica
Conditions excluded from SOP
  • carcinoid of the stomach#
  • gastroblastoma#
  • soft tissue sarcoma of the stomach*
  • non-Hodgkin lymphoma of the stomach*
  • Hodgkin lymphoma of the stomach*
  • MALT lymphoma of the stomach - non-Hodgkin lymphoma SOP
  • neuroendocrine tumour of the stomach#
  • Secondary/metastatic cancer/carcinoma involving the stomach (code to primary cancer site)

* another SOP applies

# non-SOP condition

Clinical onset

The condition typically presents at a late stage.  Unintentional weight loss, early satiety (feeling full after consuming only a small amount of food), persistent indigestion and abdominal pain are the most common symptoms.  Other presentations can include dysphagia (difficulty swallowing), nausea, vomiting, and black tarry stools (indicating gastrointestinal bleeding). 

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management.  Most people present with advanced, incurable disease and have a poor prognosis even with treatment.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-stomach-b002-c16/rulebase-malignant-neoplasm-stomach/atomic-radiation

Chronic atrophic gastritis

Current RMA Instruments
Reasonable Hypothesis SOP
74 of 2023
Balance of Probabilities SOP
75 of 2023
Changes from previous Instruments

ICD Coding

ICD-10-AM Code: C16

Brief description

Gastric cancer is one of the most common cancers worldwide, though is less common in Western countries.  There are a number of sub-types of the disease with the most common being adenocarcinoma.  This SOP covers primary epithelial cancers of the cardia, body, antrum and pyloris of the stomach. 

Confirming the diagnosis

Histology (from biopsy, an excised specimen, or autopsy) is required to confirm the diagnosis and apply the SOP.  Information on whether the primary site is the cardia of the stomach (near the oesophagus), or the rest of the stomach, will be needed to apply some of the SOP factors.

The relevant medical specialist is an oncologist, general surgeon, or gastroenterologist.

Diagnoses covered by SOP
  • adeno-, adenosquamous-, chorio-, diffuse-, intestinal-, squamous-, poorly differentiated- and undifferentiated- carcinoma of the stomach; (including mucinous, papillary, signet ring and tubular adenocarcinoma of the stomach)
  • carcinoma of the (gastric) cardia
  • carcinoma of the stomach
  • gastric carcinoma
  • linitis plastica
Conditions excluded from SOP
  • carcinoid of the stomach#
  • gastroblastoma#
  • soft tissue sarcoma of the stomach*
  • non-Hodgkin lymphoma of the stomach*
  • Hodgkin lymphoma of the stomach*
  • MALT lymphoma of the stomach - non-Hodgkin lymphoma SOP
  • neuroendocrine tumour of the stomach#
  • Secondary/metastatic cancer/carcinoma involving the stomach (code to primary cancer site)

* another SOP applies

# non-SOP condition

Clinical onset

The condition typically presents at a late stage.  Unintentional weight loss, early satiety (feeling full after consuming only a small amount of food), persistent indigestion and abdominal pain are the most common symptoms.  Other presentations can include dysphagia (difficulty swallowing), nausea, vomiting, and black tarry stools (indicating gastrointestinal bleeding). 

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management.  Most people present with advanced, incurable disease and have a poor prognosis even with treatment.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-stomach-b002-c16/rulebase-malignant-neoplasm-stomach/chronic-atrophic-gastritis

Cigar smoking

Current RMA Instruments
Reasonable Hypothesis SOP
74 of 2023
Balance of Probabilities SOP
75 of 2023
Changes from previous Instruments

ICD Coding

ICD-10-AM Code: C16

Brief description

Gastric cancer is one of the most common cancers worldwide, though is less common in Western countries.  There are a number of sub-types of the disease with the most common being adenocarcinoma.  This SOP covers primary epithelial cancers of the cardia, body, antrum and pyloris of the stomach. 

Confirming the diagnosis

Histology (from biopsy, an excised specimen, or autopsy) is required to confirm the diagnosis and apply the SOP.  Information on whether the primary site is the cardia of the stomach (near the oesophagus), or the rest of the stomach, will be needed to apply some of the SOP factors.

The relevant medical specialist is an oncologist, general surgeon, or gastroenterologist.

Diagnoses covered by SOP
  • adeno-, adenosquamous-, chorio-, diffuse-, intestinal-, squamous-, poorly differentiated- and undifferentiated- carcinoma of the stomach; (including mucinous, papillary, signet ring and tubular adenocarcinoma of the stomach)
  • carcinoma of the (gastric) cardia
  • carcinoma of the stomach
  • gastric carcinoma
  • linitis plastica
Conditions excluded from SOP
  • carcinoid of the stomach#
  • gastroblastoma#
  • soft tissue sarcoma of the stomach*
  • non-Hodgkin lymphoma of the stomach*
  • Hodgkin lymphoma of the stomach*
  • MALT lymphoma of the stomach - non-Hodgkin lymphoma SOP
  • neuroendocrine tumour of the stomach#
  • Secondary/metastatic cancer/carcinoma involving the stomach (code to primary cancer site)

* another SOP applies

# non-SOP condition

Clinical onset

The condition typically presents at a late stage.  Unintentional weight loss, early satiety (feeling full after consuming only a small amount of food), persistent indigestion and abdominal pain are the most common symptoms.  Other presentations can include dysphagia (difficulty swallowing), nausea, vomiting, and black tarry stools (indicating gastrointestinal bleeding). 

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management.  Most people present with advanced, incurable disease and have a poor prognosis even with treatment.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-stomach-b002-c16/rulebase-malignant-neoplasm-stomach/cigar-smoking

Cigarette smoking

Current RMA Instruments
Reasonable Hypothesis SOP
74 of 2023
Balance of Probabilities SOP
75 of 2023
Changes from previous Instruments

ICD Coding

ICD-10-AM Code: C16

Brief description

Gastric cancer is one of the most common cancers worldwide, though is less common in Western countries.  There are a number of sub-types of the disease with the most common being adenocarcinoma.  This SOP covers primary epithelial cancers of the cardia, body, antrum and pyloris of the stomach. 

Confirming the diagnosis

Histology (from biopsy, an excised specimen, or autopsy) is required to confirm the diagnosis and apply the SOP.  Information on whether the primary site is the cardia of the stomach (near the oesophagus), or the rest of the stomach, will be needed to apply some of the SOP factors.

The relevant medical specialist is an oncologist, general surgeon, or gastroenterologist.

Diagnoses covered by SOP
  • adeno-, adenosquamous-, chorio-, diffuse-, intestinal-, squamous-, poorly differentiated- and undifferentiated- carcinoma of the stomach; (including mucinous, papillary, signet ring and tubular adenocarcinoma of the stomach)
  • carcinoma of the (gastric) cardia
  • carcinoma of the stomach
  • gastric carcinoma
  • linitis plastica
Conditions excluded from SOP
  • carcinoid of the stomach#
  • gastroblastoma#
  • soft tissue sarcoma of the stomach*
  • non-Hodgkin lymphoma of the stomach*
  • Hodgkin lymphoma of the stomach*
  • MALT lymphoma of the stomach - non-Hodgkin lymphoma SOP
  • neuroendocrine tumour of the stomach#
  • Secondary/metastatic cancer/carcinoma involving the stomach (code to primary cancer site)

* another SOP applies

# non-SOP condition

Clinical onset

The condition typically presents at a late stage.  Unintentional weight loss, early satiety (feeling full after consuming only a small amount of food), persistent indigestion and abdominal pain are the most common symptoms.  Other presentations can include dysphagia (difficulty swallowing), nausea, vomiting, and black tarry stools (indicating gastrointestinal bleeding). 

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management.  Most people present with advanced, incurable disease and have a poor prognosis even with treatment.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-stomach-b002-c16/rulebase-malignant-neoplasm-stomach/cigarette-smoking

Infection with Helicobacter pylori

Current RMA Instruments
Reasonable Hypothesis SOP
74 of 2023
Balance of Probabilities SOP
75 of 2023
Changes from previous Instruments

ICD Coding

ICD-10-AM Code: C16

Brief description

Gastric cancer is one of the most common cancers worldwide, though is less common in Western countries.  There are a number of sub-types of the disease with the most common being adenocarcinoma.  This SOP covers primary epithelial cancers of the cardia, body, antrum and pyloris of the stomach. 

Confirming the diagnosis

Histology (from biopsy, an excised specimen, or autopsy) is required to confirm the diagnosis and apply the SOP.  Information on whether the primary site is the cardia of the stomach (near the oesophagus), or the rest of the stomach, will be needed to apply some of the SOP factors.

The relevant medical specialist is an oncologist, general surgeon, or gastroenterologist.

Diagnoses covered by SOP
  • adeno-, adenosquamous-, chorio-, diffuse-, intestinal-, squamous-, poorly differentiated- and undifferentiated- carcinoma of the stomach; (including mucinous, papillary, signet ring and tubular adenocarcinoma of the stomach)
  • carcinoma of the (gastric) cardia
  • carcinoma of the stomach
  • gastric carcinoma
  • linitis plastica
Conditions excluded from SOP
  • carcinoid of the stomach#
  • gastroblastoma#
  • soft tissue sarcoma of the stomach*
  • non-Hodgkin lymphoma of the stomach*
  • Hodgkin lymphoma of the stomach*
  • MALT lymphoma of the stomach - non-Hodgkin lymphoma SOP
  • neuroendocrine tumour of the stomach#
  • Secondary/metastatic cancer/carcinoma involving the stomach (code to primary cancer site)

* another SOP applies

# non-SOP condition

Clinical onset

The condition typically presents at a late stage.  Unintentional weight loss, early satiety (feeling full after consuming only a small amount of food), persistent indigestion and abdominal pain are the most common symptoms.  Other presentations can include dysphagia (difficulty swallowing), nausea, vomiting, and black tarry stools (indicating gastrointestinal bleeding). 

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management.  Most people present with advanced, incurable disease and have a poor prognosis even with treatment.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-stomach-b002-c16/rulebase-malignant-neoplasm-stomach/infection-helicobacter-pylori

No appropriate clinical management for malignant neoplasm of the stomach

Current RMA Instruments
Reasonable Hypothesis SOP
74 of 2023
Balance of Probabilities SOP
75 of 2023
Changes from previous Instruments

ICD Coding

ICD-10-AM Code: C16

Brief description

Gastric cancer is one of the most common cancers worldwide, though is less common in Western countries.  There are a number of sub-types of the disease with the most common being adenocarcinoma.  This SOP covers primary epithelial cancers of the cardia, body, antrum and pyloris of the stomach. 

Confirming the diagnosis

Histology (from biopsy, an excised specimen, or autopsy) is required to confirm the diagnosis and apply the SOP.  Information on whether the primary site is the cardia of the stomach (near the oesophagus), or the rest of the stomach, will be needed to apply some of the SOP factors.

The relevant medical specialist is an oncologist, general surgeon, or gastroenterologist.

Diagnoses covered by SOP
  • adeno-, adenosquamous-, chorio-, diffuse-, intestinal-, squamous-, poorly differentiated- and undifferentiated- carcinoma of the stomach; (including mucinous, papillary, signet ring and tubular adenocarcinoma of the stomach)
  • carcinoma of the (gastric) cardia
  • carcinoma of the stomach
  • gastric carcinoma
  • linitis plastica
Conditions excluded from SOP
  • carcinoid of the stomach#
  • gastroblastoma#
  • soft tissue sarcoma of the stomach*
  • non-Hodgkin lymphoma of the stomach*
  • Hodgkin lymphoma of the stomach*
  • MALT lymphoma of the stomach - non-Hodgkin lymphoma SOP
  • neuroendocrine tumour of the stomach#
  • Secondary/metastatic cancer/carcinoma involving the stomach (code to primary cancer site)

* another SOP applies

# non-SOP condition

Clinical onset

The condition typically presents at a late stage.  Unintentional weight loss, early satiety (feeling full after consuming only a small amount of food), persistent indigestion and abdominal pain are the most common symptoms.  Other presentations can include dysphagia (difficulty swallowing), nausea, vomiting, and black tarry stools (indicating gastrointestinal bleeding). 

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management.  Most people present with advanced, incurable disease and have a poor prognosis even with treatment.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-stomach-b002-c16/rulebase-malignant-neoplasm-stomach/no-appropriate-clinical-management-malignant-neoplasm-stomach

Partial gastrectomy

Current RMA Instruments
Reasonable Hypothesis SOP
74 of 2023
Balance of Probabilities SOP
75 of 2023
Changes from previous Instruments

ICD Coding

ICD-10-AM Code: C16

Brief description

Gastric cancer is one of the most common cancers worldwide, though is less common in Western countries.  There are a number of sub-types of the disease with the most common being adenocarcinoma.  This SOP covers primary epithelial cancers of the cardia, body, antrum and pyloris of the stomach. 

Confirming the diagnosis

Histology (from biopsy, an excised specimen, or autopsy) is required to confirm the diagnosis and apply the SOP.  Information on whether the primary site is the cardia of the stomach (near the oesophagus), or the rest of the stomach, will be needed to apply some of the SOP factors.

The relevant medical specialist is an oncologist, general surgeon, or gastroenterologist.

Diagnoses covered by SOP
  • adeno-, adenosquamous-, chorio-, diffuse-, intestinal-, squamous-, poorly differentiated- and undifferentiated- carcinoma of the stomach; (including mucinous, papillary, signet ring and tubular adenocarcinoma of the stomach)
  • carcinoma of the (gastric) cardia
  • carcinoma of the stomach
  • gastric carcinoma
  • linitis plastica
Conditions excluded from SOP
  • carcinoid of the stomach#
  • gastroblastoma#
  • soft tissue sarcoma of the stomach*
  • non-Hodgkin lymphoma of the stomach*
  • Hodgkin lymphoma of the stomach*
  • MALT lymphoma of the stomach - non-Hodgkin lymphoma SOP
  • neuroendocrine tumour of the stomach#
  • Secondary/metastatic cancer/carcinoma involving the stomach (code to primary cancer site)

* another SOP applies

# non-SOP condition

Clinical onset

The condition typically presents at a late stage.  Unintentional weight loss, early satiety (feeling full after consuming only a small amount of food), persistent indigestion and abdominal pain are the most common symptoms.  Other presentations can include dysphagia (difficulty swallowing), nausea, vomiting, and black tarry stools (indicating gastrointestinal bleeding). 

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management.  Most people present with advanced, incurable disease and have a poor prognosis even with treatment.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-stomach-b002-c16/rulebase-malignant-neoplasm-stomach/partial-gastrectomy

Pipe smoking

Current RMA Instruments
Reasonable Hypothesis SOP
74 of 2023
Balance of Probabilities SOP
75 of 2023
Changes from previous Instruments

ICD Coding

ICD-10-AM Code: C16

Brief description

Gastric cancer is one of the most common cancers worldwide, though is less common in Western countries.  There are a number of sub-types of the disease with the most common being adenocarcinoma.  This SOP covers primary epithelial cancers of the cardia, body, antrum and pyloris of the stomach. 

Confirming the diagnosis

Histology (from biopsy, an excised specimen, or autopsy) is required to confirm the diagnosis and apply the SOP.  Information on whether the primary site is the cardia of the stomach (near the oesophagus), or the rest of the stomach, will be needed to apply some of the SOP factors.

The relevant medical specialist is an oncologist, general surgeon, or gastroenterologist.

Diagnoses covered by SOP
  • adeno-, adenosquamous-, chorio-, diffuse-, intestinal-, squamous-, poorly differentiated- and undifferentiated- carcinoma of the stomach; (including mucinous, papillary, signet ring and tubular adenocarcinoma of the stomach)
  • carcinoma of the (gastric) cardia
  • carcinoma of the stomach
  • gastric carcinoma
  • linitis plastica
Conditions excluded from SOP
  • carcinoid of the stomach#
  • gastroblastoma#
  • soft tissue sarcoma of the stomach*
  • non-Hodgkin lymphoma of the stomach*
  • Hodgkin lymphoma of the stomach*
  • MALT lymphoma of the stomach - non-Hodgkin lymphoma SOP
  • neuroendocrine tumour of the stomach#
  • Secondary/metastatic cancer/carcinoma involving the stomach (code to primary cancer site)

* another SOP applies

# non-SOP condition

Clinical onset

The condition typically presents at a late stage.  Unintentional weight loss, early satiety (feeling full after consuming only a small amount of food), persistent indigestion and abdominal pain are the most common symptoms.  Other presentations can include dysphagia (difficulty swallowing), nausea, vomiting, and black tarry stools (indicating gastrointestinal bleeding). 

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management.  Most people present with advanced, incurable disease and have a poor prognosis even with treatment.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-stomach-b002-c16/rulebase-malignant-neoplasm-stomach/pipe-smoking

Smoking tobacco products - material contribution

Current RMA Instruments
Reasonable Hypothesis SOP
74 of 2023
Balance of Probabilities SOP
75 of 2023
Changes from previous Instruments

ICD Coding

ICD-10-AM Code: C16

Brief description

Gastric cancer is one of the most common cancers worldwide, though is less common in Western countries.  There are a number of sub-types of the disease with the most common being adenocarcinoma.  This SOP covers primary epithelial cancers of the cardia, body, antrum and pyloris of the stomach. 

Confirming the diagnosis

Histology (from biopsy, an excised specimen, or autopsy) is required to confirm the diagnosis and apply the SOP.  Information on whether the primary site is the cardia of the stomach (near the oesophagus), or the rest of the stomach, will be needed to apply some of the SOP factors.

The relevant medical specialist is an oncologist, general surgeon, or gastroenterologist.

Diagnoses covered by SOP
  • adeno-, adenosquamous-, chorio-, diffuse-, intestinal-, squamous-, poorly differentiated- and undifferentiated- carcinoma of the stomach; (including mucinous, papillary, signet ring and tubular adenocarcinoma of the stomach)
  • carcinoma of the (gastric) cardia
  • carcinoma of the stomach
  • gastric carcinoma
  • linitis plastica
Conditions excluded from SOP
  • carcinoid of the stomach#
  • gastroblastoma#
  • soft tissue sarcoma of the stomach*
  • non-Hodgkin lymphoma of the stomach*
  • Hodgkin lymphoma of the stomach*
  • MALT lymphoma of the stomach - non-Hodgkin lymphoma SOP
  • neuroendocrine tumour of the stomach#
  • Secondary/metastatic cancer/carcinoma involving the stomach (code to primary cancer site)

* another SOP applies

# non-SOP condition

Clinical onset

The condition typically presents at a late stage.  Unintentional weight loss, early satiety (feeling full after consuming only a small amount of food), persistent indigestion and abdominal pain are the most common symptoms.  Other presentations can include dysphagia (difficulty swallowing), nausea, vomiting, and black tarry stools (indicating gastrointestinal bleeding). 

Clinical worsening

The only SOP worsening factor is for inability to obtain appropriate clinical management.  Most people present with advanced, incurable disease and have a poor prognosis even with treatment.

 

Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/m/malignant-neoplasm-stomach-b002-c16/rulebase-malignant-neoplasm-stomach/smoking-tobacco-products-material-contribution